The amount of the transaction was not disclosed. In conjunction with the funding, Aaron Davis, Principal, and Phil Molner, Managing Partner of Primus, will join Forte’s Board of Directors.
Led by Srini Kalluri, Founder, President, CEO, and Chief Customer Officer, Forte develops and supports clinical research management software, collaborating with the clinical research community to develop standards-based systems which promote best practices throughout the industry.
Forte’s software is used at NCI-designated cancer centers and NIH-funded clinical and translational science awardee organizations, academic medical centers, healthcare systems, and research sites throughout the United States. It has supported more than 80,000 protocols and 1 million subjects through its clinical trial management systems, OnCore® Enterprise Research and Allegro® CTMS. The company also provides electronic data capture software, Overture® EDC, for CROs and sponsors.